Sabio Holdings Inc. (SBIO:CA) Q2 2026 Earnings Call Transcript

Sabio Holdings Inc. (SBIO:CA) Q2 2026 Earnings Call Transcript

Seeking Alpha • Aug 20, 2026

3 Small-Cap ETFs to Watch as Russell 2000 Hits Record

The Russell 2000 closed at a new record high Friday amid continued upwards momentum for several market indexes. That index, with its focus on small-caps, could prove an intriguing source of investing opportunities, given the right approach.

ETF Trends • Aug 17, 2026

Risk-Wary Family Offices Double Down on Infrastructure

Geopolitical shocks have pushed family offices to rethink nearly every corner of their portfolios. Infrastructure has emerged as the asset class they trust most right now.

ETF Trends • Jul 21, 2026

Big Pharma's $300 Billion Patent Problem Fuels Biotech Deals

Big Pharma has a $300 billion problem, and biotech developers with promising drugs are becoming the fix. Major drugmakers are spending at a pace not seen since 2019 to replace medicines that will soon lose patent protection.

ETF Trends • Jul 13, 2026

Should You Invest in the ALPS Medical Breakthroughs ETF (SBIO)?

Designed to provide broad exposure to the Healthcare - Broad segment of the equity market, the ALPS Medical Breakthroughs ETF (SBIO) is a passively managed exchange traded fund launched on December 31, 2014.

Zacks Investment Research • Jul 9, 2026

SBIO: Biotech Breakthrough Opportunities Screened For Cash Burn

ALPS Medical Breakthroughs ETF targets late-stage clinical trial biotechs primed for outsized performance and M&A. SBIO's selective criteria focus on U.S.-listed firms with strong cash positions, Phase 2/3 assets, and near-term catalysts, creating a portfolio of high-volatility, high-alpha 'lottery tickets.' SBIO has delivered 111% returns over the past year, outperforming the S&P 500; its holdings have seen notable buyouts and clinical milestones.

Seeking Alpha • Jul 7, 2026

Biotech Gives SBIO Its Best Month Since 2023

Biotech stocks delivered their best single month since late 2023 in June, carrying the ALPS Medical Breakthroughs ETF (SBIO) to one of the top returns across the ALPS lineup. Key Takeaways: SBIO returned 18.7% in June, its best single month since December 2023.

ETF Trends • Jul 2, 2026

June's Top ETFs: Biotech & China Semiconductors Surge

June has been a month full of excitement in the ETF market. While commercial space and AI infrastructure attracted a significant amount of investor attention, biotechnology exposure comprises four out of the five top-performing equity ETFs as of June 29.

ETF Trends • Jul 1, 2026

Biotech ETF Index Surges 10% After Rebalance

After a sweeping semi-annual rebalance, the biotech index underlying the ALPS Medical Breakthroughs ETF (SBIO) gained over 10% in just six trading days beginning June 18. Key Takeaways: SBIO's underlying index gained 10.01% in six trading days following its June 18 semi-annual rebalance.

ETF Trends • Jun 25, 2026

Biotech ETFs Gain Momentum via AI Drug Discovery & Surging M&A

The biotechnology sector has broken out of its multiyear bear market. As macroeconomic headwinds moderate and regulatory environments stabilize, biotech ETFs are surging.

ETF Trends • Jun 23, 2026